Biotechnology: Present and Future Roles in the Pharmaceutical Industry
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 11 (5) , 965-999
- https://doi.org/10.3109/03639048509055593
Abstract
Biotechnology is the integration of a number of scientific disciplines including microbiology, genetics, biochemistry and chemical engineering. It uses living organisms, or systems or products from these organisms to make or modify useful products. New biotechnology comprises genetic engineering, protoplast fusion and monoclonal antibody techniques, powerful new “tools” designed to generate efficient bioprocesses and products for the pharmaceutical industry. The following areas of biotechnology are highlighted: human insulin, interferons and other growth factors, neuroactive peptides, blood products, antibiotics, enzymes, monoclonal antibodies, vaccines and oncogenes.This publication has 7 references indexed in Scilit:
- Expression of Cellular Oncogenes in Human MalignanciesScience, 1984
- Bioreactors: Design and OperationScience, 1983
- Strain Improvement and Preservation of β-Lactam-Producing MicroorganismsPublished by Springer Nature ,1983
- OncogenesScientific American, 1982
- Oncogenes of Spontaneous and Chemically Induced TumorsAdvances in Cancer Research, 1982
- The clinical value of interferons as antitumor agentsEuropean Journal of Cancer and Clinical Oncology, 1981
- Synthesis of hepatitis B surface and core antigens in E. coliNature, 1981